FDA 483 - Steuart Contract Packaging - May 07, 2026
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Steuart Custom Products, Inc. in Le Roy, MN, a drug manufacturer, revealed significant deficiencies across multiple systems. The firm failed to adequately validate cleaning processes for shared equipment, qualify upgraded manufacturing equipment, and implement proper controls for computer systems to ensure data integrity. Additionally, the environmental monitoring program was found to be insufficient for preventing objectionable microorganisms in non-sterile drug products.
- Person
ID · 60456cbc-63da-4800-88fb-f8648c49c1b3